Designing a novel drug–drug conjugate as a prodrug for breast cancer therapy: in silico insights
Crossref DOI link: https://doi.org/10.1007/s11030-024-10886-w
Published Online: 2024-06-04
Published Print: 2025-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Muthumanickam, Sankar
Ramachandran, Balajee
Jeyakanthan, Jeyaraman
Jegatheswaran, Sonamuthu
Pandi, Boomi
Text and Data Mining valid from 2024-06-04
Version of Record valid from 2024-06-04
Article History
Received: 31 December 2023
Accepted: 24 April 2024
First Online: 4 June 2024
Declarations
:
: There are no conflicts to declare.